Dr. Andrea Persaud is a BOARD CERTIFIED DERMATOLOGIST and Diplomate of the American Board of Dermatology, who practices both medical and cosmetic dermatology in New York City.

Dr. Persaud is Clinical Assistant Professor of Dermatology at New York University School of Medicine. She completed her residency in dermatology at the Mount Sinai School of Medicine, New York University. She received her MD degree at the Mount Sinai School of Medicine, and completed her medical internship at NYU/Bellevue Hospital of New York University.

Dr. Persaud has extensive research experience in dermatopharmacology, conducting over 100 clinical trials. Dr. Persaud holds several fellowships in dermatopharmacology in the Department of Dermatology at the Mount Sinai School of Medicine and Ronald O. Perelman Department of Dermatology, New York University School of Medicine. One of her widely recognized work on treating pre-cancerous skin lesions (actinic keratoses) with a topical immunomodulator (imiquimod cream) was approved by the FDA.

Dr. Persaud has spoken at conferences nationally and internationally, and is often quoted in the media and newsletters about her work on treating pre-cancerous skin lesions with a topical immunomodulator cream. Widely published in many medical journals, Dr. Persaud has also published and presented more than 30 clinical research and case report abstracts at various medical conferences and in journals. She has also written a book chapter on psoriasis. She regularly attends American Academy of Dermatology conferences and other dermatology meetings, and serves as a reviewer for various dermatological journals and books. Dr. Persaud is an active member of the National Psoriasis Foundation.

Dr. Persaud is also co-founder of Yauvan Professional Skin Care and serves as the Vice-President of Yauvan Corporation.

Dr. Persaud's biography is listed in Who's Who in the World, Who's Who in America , and Who's Who in American Women, Who's Who in Medicine and Healthcare and Who's Who of Emerging Leaders..

Dr. Persaud in Media and Newsletters

Live at Five News on Channel 7: Topical Tacrolimus in Atopic Dermatitis. June 2001. Andrea N. Persaud, M.D.
EyeWitness News on channel 7: Topical Tacrolimus in Atopic Dermatitis. In 2000. Andrea N. Persaud, M.D.
Video Interview: Tacrolimus (Protopic Ointment) for the treatment of pruritus/atopic dermatitis. Fujisawa Healthcare, Feb 2000. Andrea N. Persaud, M.D.
National Psoriasis Foundation: Psoriasis Forum. Management of Pustular Psoriasis. Fall 1999, Vol 5, No.3. Andrea N. Persaud, M.D. and Mark Lebwohl, M.D.
Skin & Allergy News: Media Coverage of Vitamin E Modulation of Retinoid Toxicity. February 1999, Vol.30, No.2. Andrea N. Persaud, M.D.
The Oclassen Dermatology New Media Project: Topical Therapies for Psoriasis. Access through American Academy of Dermatology Website. Andrea N. Persaud, M.D. and Mark Lebwohl, M.D.